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ABSTRACT
Background. Living donor kidney transplantation (LDKT) is the preferred treatment for patients with end-stage renal disease
and unspecified living kidney donation is morally justified. Despite the excellent outcomes of LDKT, unspecified kidney
donation (UKD) is limited to a minority of European countries due to legal constraints and moral objections. Consequently,
there are significant variations in practice and approach between countries and the contribution of UKD is undervalued. Where
UKD is accepted as routine, an increasing number of patients in the kidney exchange programme are successfully transplanted
when a ‘chain’ of transplants is triggered by a single unspecified donor. By expanding the shared living donor pool, the benefit
of LDKT is extended to patients who do not have their own living donor because a recipient on the national transplant list
always completes the chain. Is there a moral imperative to increase the scope of UKD and how could this be achieved?
Methods. An examination of the literature and individual country practices was performed to identify the limitations on
UKD in Europe and recommend strategies to increase transplant opportunities.
Results. Primary limitations to UKD, key players and their roles and responsibilities were identified.
Conclusions. Raising awareness to encourage the public to volunteer to donate is appropriate and desirable to increase UKD.
Recommendations are made to provide a framework for increasing awareness and engagement in UKD. The public, healthcare
professionals, policy makers and society and religious leaders have a role to play in creating an environment for change.
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INTRODUCTION AND BACKGROUND
Living donor kidney transplantation (LDKT) is the preferred
treatment for patients with end-stage renal disease (ESRD); both
recipient and graft survival are excellent and better than for de-
ceased donor organs [1]. The concept of healthy volunteers do-
nating an organ to a family member or loved one has become
routine in many countries and represents a philosophical shift
in clinical practice [2]. The increasing contribution of LDKT
worldwide indicates that, within appropriate frameworks and
agreed boundaries of best practice, it is considered morally ac-
ceptable and healthcare professionals are committed to it [3–5].
Proponents of LDKT actively engage with loved ones to seek
transplant opportunities for their patients, promoting strategies
and interventions to create equity of access across all sectors of
society, regardless of ethnicity, religion or culture [6–9].
Approaches to living organ donation (LOD) vary between
countries according to national policy, which influences access
to deceased donor kidney transplantation and LDKT and
informs rules about donor protection, public awareness cam-
paigns and education programmes. The lack of universal sup-
port, both legally and philosophically, for unspecified kidney
donation (UKD) is striking [3]. Scepticism about the motivations
of the healthy volunteer ‘altruistic donor’ remains at the core of
legal and social policies but, there is no evidence that UKD is
detrimental to the donor or society [10–12]. In most European
countries that support LOD, ‘relatedness’ between donor and re-
cipient (specified donation) is legally mandated [13–15]. The ge-
netic and/or emotional relationship between donor and
recipient has provided historical moral justification for LOD,
and the absence of such relationships in unspecified donation
(UD) has made some countries reluctant to adopt a legal frame-
work to support it [3].
In the Netherlands and UK, where there has been a signifi-
cant expansion in UKD, an increasing number of patients in the
kidney exchange programme are successfully transplanted
when a ‘chain’ of transplants is triggered by a single unspecified
donor. UKD is also permitted in other countries, including
Sweden, Spain, Italy, Czech Republic, Austria and Finland, but
activity remains low and is poorly differentiated in global
reports [2]. Table 1 shows activity from countries where it has
been possible to obtain UD data through personal contacts [2, 3].
In the Netherlands, unspecified donors are encouraged to enter
the national kidney exchange programme but may be matched
locally in a ‘domino chain’ or to a recipient on the national wait-
ing list if they prefer not to travel to another centre. Any number
of matches can be identified in a single exchange provided that
multiple donor and recipient operations can be performed si-
multaneously. Simultaneous matching runs for unspecified
donors and the kidney crossover programme have recently
been introduced and the donor usually travels between the do-
nating and receiving hospitals. There is no apparent impact on
outcome if the kidney, rather than the donor, travels [1].
In the UK, unspecified donors enter the United Kingdom
Living Kidney Sharing Scheme (UKLKSS) to initiate a chain of up
to three transplants from a single donation unless there is a
high priority recipient on the national transplant list to whom
they donate instead. Simultaneous matching runs for altruistic
donor chains and paired/pooled donations are preferred but
non-simultaneous surgery is also permitted to overcome logisti-
cal challenges such as theatre availability. The UK algorithm for
allocation of deceased donor kidneys is used to identify a single
recipient on the national transplant list either to complete a
chain or for donors who do not enter a chain. Typically, the do-
nated kidney travels to the recipient receiving centre.
The contribution of UKD to the shared living donor pool is
invaluable, particularly for long-waiting patients with immuno-
logical complexity due to high levels of human leucocyte anti-
gen antibodies and recipients from Black and Asian minority
ethnic (BAME) communities [1, 16, 17]. The utility of this ap-
proach provides a distinct and important reason to support
UKD.
In the Netherlands, UD accounts for 1.5% of living kidney
donors in the largest single centre performing LDKT (Table 1).
These donors, together with those who donate anonymously to
a ‘paired recipient’ in the kidney exchange programme, account
for 17% of the national living donor pool [18]. In the UK, despite
a fall in the absolute numbers of unspecified donors, they ac-
count for 21% of transplants within the UKLKSS by donating
into a ‘chain’, which is an increasing trend [1]. Increasing activ-
ity has stimulated research and informed national strategies to
support clinical programmes [12, 17, 19, 20]. The role of publicity
and media in influencing the public and their willingness to do-
nate has been evident. Global access to communication through
the Internet and social media has prompted offers of donation
from non-residents without access to UD in their own countries,
generating a need for clear guidance and agreed policies to sup-
port clinical practice [21–23].
UD is not organ-specific but is predominantly UKD, reflect-
ing clinical preference for kidney rather than lobe of liver dona-
tion in countries where UD has evolved. The perception of risk
for the living liver donor has undoubtedly influenced activity—
the UK and the Netherlands report cases of unspecified liver
donors representing <1% of UD activity [1, 18]. Unspecified liver
Table 1. UKD activity by countrya
Country
Living donor transplants as a
percentage of all transplantsb
Total number of unspecified kidney
donors (at December 2018)
Unspecified donors as a
percentage of all living donors Year of first UD
Czech Republic 11 (n ¼ 51) 5 0.9 2008
Italy 14 (n ¼ 313) 7 0.6 2015
The Netherlands 56 (n ¼ 551) 160c 1.5c 2000
Spain 10 (n ¼ 332) 13 0.5 2011
Sweden 26 (n ¼ 125) 26 1.5 2004
UK 29 (n ¼ 1000) 699 8 2007
aCountry-specific UD data courtesy of co-authors (the Netherlands, Sweden, UK) and personal contacts, Jiri Fronek (Czech Republic); Paola di Ciaccio (Italy); M.O.
Valentin (Spain).
bFrom Transplant Newsletter 2017 [2].
cData from the largest single centre (Rotterdam) only. All centre data not available for the Netherlands.
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donation may be seen as an unwelcome consequence of a UD
programme; conferring more risk on the donor, creating oppor-
tunities for ‘serial’ UD and adding further clinical and moral
complexity to a controversial practice [11].
This article focuses on UKD to examine the limitations of UD
in Europe and to recommend strategies to increase transplant
opportunities for patients with ESRD by:
(i) raising awareness and
(ii) engaging with key audiences.
These recommendations reflect experience from countries
where engagement initiatives have been successful in achieving
an ethical expansion of the living donor pool and UKD activity.
Successful implementation depends upon the maturity and
characteristics of individual LDKT programmes. Appropriate in-
frastructure, organisational frameworks and clinical pathways
must be established to facilitate donation and safeguard the
interests of people who volunteer to donate.
LIMITATIONS AND KEY PLAYERS
Table 2 identifies the primary limitations to the development of
UKD. The categories are interdependent and influenced by key
players, who shape and define the environment, culture and in-
frastructure that supports national LOD and UKD programmes.
The key players are classified into those:
(i) Specifically dedicated to UKD (e.g. previous living donors
and donor associations)
(ii) With a generic role within transplantation, from a clinical
(professionals), legal and organisational (competent au-
thority and procurement organisations) or wider commu-
nity (government, media, religious and society leaders)
perspective.
By identifying the barriers and understanding their source
and impact, we have defined scalable recommendations to
overcome them.
Legal framework, resources and infrastructure
The scope of LOD and UD is inevitably curtailed where the pre-
vailing national view is non-permissive [2, 3]. There are legal
prohibitions on LOD in all European Union countries to safe-
guard potential donors from coercion and reward and to protect
vulnerable people from organ trafficking [3, 4, 23]. Arguments
that underpin legal limitations solely on the basis of the rela-
tionship between donor and recipient exist in many European
countries [3]. Such restrictions preclude UD and argue for donor
protection, primarily on the basis of non-maleficence and vol-
untariness, rather than objective criteria such as an individual’s
physical and psychological suitability to donate.
These prescriptive limitations presume that a close or val-
ued donor–recipient relationship, where the donor is ‘altruisti-
cally’ motivated by recipient benefit, provides a ‘core of
acceptability’ to an act of donation. While the impact of recipi-
ent benefit may be true, there is a ‘spectrum of altruism’—in-
cluding self-interest, reciprocity and obligation—associated
with donation between family members and friends that is con-
sidered morally acceptable. This ‘spectrum’ does not detract
from the typically selfless act or from the sense of personal and
individual identity that motivates loved ones to donate but, re-
alistically describes the motivation and moral complexity that
underpins decision-making in LOD [24]. The morality of an indi-
vidual’s decision to donate is determined by the intrinsic value
and integrity of the decision itself. The moral code that guides
‘all’ donors is complex, but relationships based upon genetics,
love or emotion do not provide the only legitimate reasons to
donate. For unspecified kidney donors, the ‘core of moral ac-
ceptability’ associated with close donor–recipient relationships
is absent but the act of UD to an anonymous recipient is, ‘prima
facie’, more selfless than donation to a spouse or partner or
even to a child. There is no reciprocity for the unspecified donor
as there is within a shared relationship, or sense of obligation
when a parent donates to a child. Obligation has many guises:
‘absolute’ (between parent and child), ‘relative’ (the desire to
help a spouse, partner or friend), almost ‘theoretical’ (in the
context of an estranged family member). A sense of ‘societal’
obligation (to help someone in need of a transplant) from the
unspecified donor is no less laudable because his/her recipient
is anonymously identified. Yet, UD is still viewed with scepti-
cism, placing an increased burden upon donors to provide legal
and moral justification for their wish to donate.
Without a legal mandate, there is little incentive to develop
the necessary infrastructure and resources to support a LOD
programme but, in countries where there is a permissive legal
framework, establishing sufficient capacity and capability to
fulfil the LOD potential can also be a challenge [19, 25].
Ethnicity and culture
There is little published data available about ethnicity and cul-
ture in the specific context of UKD, but the latest statistics from
National Health Service Blood and Transplant (NHSBT) shows
UK trends within BAME communities [1]. Unspecified donors
are typically White, aged between 50 and 85 years (median
50 years) with equivalent numbers of male (51%) and female
(48%) donors. About 14% of the UK population is from BAME
communities but only 1% of unspecified donors are from these
communities, with more Asians than Blacks donating.
Although 25% of unspecified donor kidneys are transplanted
into BAME recipients and 24% receive kidneys through kidney
exchange programmes [1], people from BAME communities are
more likely to donate to family or friends than to society [6–9].
The need for and reduced access to kidney transplantation
for BAME populations is well documented due to predisposition
to kidney disease, cultural and religious beliefs and potential
Table 2. Primary limitations to UKD and key players
Primary limitations Key players
(i) Lack of legal framework,
infrastructure and
resources to support LOD
6 UD
Policy makers
Competent authorities
Commissioners
(ii) Ethnicity and culture Society and religious leaders
Public, donors, recipients and families
(iii) Low societal awareness
of options for LOD
Society and religious leaders
Public, donors, recipients and families
Patient/donor associations
Media
(iv) Risk aversion—‘do no
harm’
Policy makers
Commissioners
Procurement organisations
Healthcare professionals
Professional societies
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barriers to communication [1, 8, 9, 26–28]. Different approaches,
adapted to social demography, community subsets and their
specific beliefs and cultural needs, are necessary to encourage
engagement about donation and transplantation. Home educa-
tion, in conjunction with hospital-based interventions, has
been successful in the Netherlands and USA to improve engage-
ment and understanding between healthcare professionals,
patients and their families [6–9]. Given their predisposition to
lifelong risk of kidney disease, living donors from these commu-
nities must be selected carefully, which is reflected in UK best-
practice guidelines [29]. This should not preclude awareness
campaigns and public engagement initiatives to inform them
about the potential benefits of LOD and UKD and its contribu-
tion to the overall transplantation programme.
Low societal awareness
Even in countries where UD is an accepted norm, public aware-
ness is poor (Kantar Public) and there may be reticence to ad-
dress it. In contrast to the approach to deceased organ, tissue,
blood and bone marrow donation, promotional campaigns to
actively engage with all sectors of society are not routine. To un-
derstand these differences, it is helpful to define the terminol-
ogy and understand the implications in the context of LOD.
Promotion is defined as actions to deliver a specific outcome
[30]. This may include encouraging progress of a particular issue
or idea in the case of deceased organ donation; it is appropriate
to ‘promote’ an increase in donation rates to create transplant
opportunities. Promotion is also used to encourage sales (of a
product) through active marketing or advertising and/or by se-
curing financial support. In this context, promotion of LOD
through targeted public campaigns may have negative connota-
tions such as solicitation, coercion, commercialisation and
commodification. These are not aligned with the concept of ‘a
gift, freely given’.
The principle of donor protection—safeguarding every vol-
unteer donor, proportionate to the risk—is fundamental to how
the promotion of LOD and particularly UD is perceived. The ‘hi-
erarchy of acceptability’ relates to how ‘routine’ or ‘exceptional’
a practice is and, hence, the balance of risk associated with it.
The willingness to promote lower risk activities with increased
utility such as blood donation and deceased organ donation is
greater than for activities that are believed to carry higher risk,
even if there is proven benefit. In LOD, this includes considera-
tions about the type of organ that is being donated and to
whom, individual donor risk versus recipient outcome, and rep-
utational risk to the overall organ donation and transplantation
programme.
The relationship between the learning curve and the willing-
ness for procurement organisations and healthcare professio-
nals to actively promote LOD is apparent: even in established
programmes where clinicians actively endorse specified dona-
tion with friends and family, there is variable enthusiasm for
UD [1].
In contrast to promotion, raising awareness provides knowl-
edge and information to support choices, autonomous decision-
making and free and voluntary consent [30–33]. For these rea-
sons, raising public awareness has advantages over active pro-
motion in the context of LOD, and especially UD, where donors
volunteer from all sectors of society. It creates opportunity to
provide public information programmes that reinforce the prin-
ciples of LOD, supports the rights of the person choosing to do-
nate and removes ambiguity about public solicitation or
targeted recruitment of potential donors [22, 34, 35]. A survey
commissioned by NHSBT in January 2017 (Kantar Public)
showed that 52% of the population were ‘unaware’ of living kid-
ney donation but having been ‘made aware’, 62% of people con-
sidered donating to a family member or friend and 22% to
someone they did not know (Kantar Public).
The distinction between promotion and raising awareness,
in terms of outcome, is narrow; both aim to encourage public
engagement and organ donation. However, the principle of free
and informed choice lies at the heart of LOD and UD is breaking
boundaries of international clinical practice. A process driven
by donor choice, rather than one promoted by healthcare pro-
fessionals and organ procurement organisations, inspires confi-
dence and engagement from the public, wider transplant
community and policymakers.
Risk aversion—‘do no harm’
In countries where UKD is well established, it is a ‘donor-driven’
process. The willingness of clinicians to actively promote LOD
to family and friends in comparison with UD is akin to the early
days of LDKT, before it became fully embedded. The UD pro-
gramme remains a learning curve, and is typically perceived as
higher risk, in comparison with specified donation, because of
it.
There is inherent risk of death and comorbidity associated
with LDKT, reflected in European and national guidelines.
Careful preparation and assessment of all donors are recom-
mended to ameliorate risk [5, 21–23, 27, 33]. The role of donor–
recipient relationships in defining relative risk or motivation to
donate has already been discussed and, in itself, should not be a
barrier to donation. For example, there is no evidence to sug-
gest, in the case of two living kidney donors—one donating di-
rectly to a family member, the other anonymously—both
clinically suitable to donate, with identical characteristics and
equivalent surgical risk, that one is more exposed to physical
harm than the other. In terms of psychological harm, there is
limited evidence available but a lack of emotional proximity to
the recipient does not appear to be detrimental to the donor [11,
12, 20, 24, 36, 37]. Anecdotally, unspecified donors often cite this
as a ‘positive’ benefit, absolving them of any emotional obliga-
tion beyond the act of donation. The voluntary nature of UD is
potentially less equivocal than specified donation, where the
‘spectrum of obligation’ owed to a family member or identified
recipient is more likely to invoke concerns about coercion and
reward.
Initially, professionals were sceptical about UD, questioned
donor motivation and were reticent to engage with the pro-
gramme. Concerns about reinforcing narcissistic behaviour and
impact on long-term health added to the unease [10, 15, 20]. As
UKD has become more routine, it has become increasingly ac-
cepted. There is little published literature examining the atti-
tudes of healthcare professionals but there is anecdotal
evidence in the UK to suggest that kidney transplant professio-
nals perceive UD differently from specified donation. The po-
tential harm caused to patients on the waiting list, deprived of
the opportunity for transplantation due to limitations on UD,
does not appear to counter concerns about UKD per se. A multi-
centre prospective cohort study is in progress in the UK to better
understand the barriers to UD [25].
An unintended consequence in countries with active UKD
programmes is to encourage donor offers for previously un-
known, specified recipients. These are often identified through
personal campaigns or stories posted on social media. Social
media raises the ‘fear factor’ because it blurs the boundaries
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between raising awareness, advertising and offering payment
for LOD [35]. At a practical level, specified donation to a previ-
ously unknown recipient, while legally permissible, remains
controversial and a challenge to the clinical community [38].
The concern is that, if every donor ‘chose’ their recipient, there
would be an unfair distribution of these typically high quality
living donor organs and other suitable recipients would miss
out on the chance of a transplant. The counter argument is that
every additional donation removes a patient from the waiting
list and reduces overall demand for a scarce supply of suitable
kidneys for transplant. In the UK, few cases of social media-
driven specified donations have come to fruition, but each re-
cipient appeal generates a high number of self-referrals from
potential donors, which is resource intensive and requires effec-
tive management. Donors who are incompatible with their
‘specified’ recipient may consider UKD instead. Clear consensus
guidelines are helpful in agreeing a consistent approach and ed-
ucating donors and recipients is essential to manage their
expectations [39].
Another unintended consequence of UKD is the interest gen-
erated in UD of other organs such as lobe of liver. Taking UD be-
yond kidney donation is controversial and raises the possibility
of ‘serial’ organ donation in a single donor [11]. Again, consen-
sus guidelines are needed to define possible adverse conse-
quences and to support transplant teams to foster best practice
in these complex cases [40].
DEFINING THE AUDIENCES
To create change, there must be a sense of urgency and an envi-
ronment to facilitate change. Failure to engage with the concept
of UKD denies healthy volunteers the opportunity to donate
and patients miss out on the chance of a successful kidney
transplant and freedom from dialysis. This is an urgent prob-
lem. Using the primary limitations as our focus, different audi-
ences were defined amongst the key players according to their
individual roles and responsibilities (Table 3). By understanding
the information needs of the different audiences and targeting
information appropriately, recommendations could be made for
use in European countries to improve awareness and facilitate
engagement. Audiences are identified as:
(i) targets—those to whom awareness initiatives about UKD
are directed and
(ii) influencers—those who work to bring about change at an
individual, institutional or societal level.
Target audiences
The public audiences are defined by how much they have di-
rectly or indirectly been exposed to or engaged with LOD and/or
the healthcare system. For each of these audiences, the ap-
proach needs to be sensitive to social demography, circumstan-
ces, culture and beliefs and tailored to previous knowledge and
experience. The general public need messages to raise overall
awareness and to address issues of trust, concern and scepti-
cism. The interested public are more likely to respond to an ap-
peal that sparks a latent desire to do something good for
someone else [12], while the engaged public will have more
complex information needs, depending upon their previous
knowledge and experience as patients or family members.
Healthcare professionals working across all sectors are both
‘targets’ and ‘influencers’ and are well represented within
cohorts of unspecified donors. Professionals working outside
organ donation and transplantation, particularly in primary and
secondary care, may not have specialist knowledge but will pro-
vide advice and/or act as initial points of contact for people con-
sidering donation. To enable them to raise awareness and
respond appropriately to expressions of interest from the pub-
lic, they represent a target audience with specific educational
needs.
Professionals working in the field of donation, transplanta-
tion and nephrology fall into both audiences; they are all ‘influ-
encers’ but depending upon their specialism or proximity to
transplantation may require education and training to keep
them updated. As ambassadors and advocates for their
patients, their active participation is necessary to ensure con-
sistent messaging, inspire public confidence and engage with
public awareness campaigns [24]. Conflict can arise if clinicians
have personal views about LOD and UKD, which influence their
clinical practice. Strong views about particular groups of people
based on age, ethnicity or motivation may impact upon the ac-
ceptance of referrals and donor satisfaction, and jeopardize the
reputation of the programme. Early involvement and collabora-
tion, and consistent, best practice guidelines are important to
engage and update clinicians [21–23, 33, 39].
The development of UKD has provided rich opportunities for
research. Retrospective studies provide insight into the early ex-
perience of UD and inform approaches to publicity and target
audiences [3, 12, 14, 20, 24]. Further prospective research will in-
form future guidance and discussion in this rapidly evolving
area of LOD practice [25].
Influencers
Healthcare professionals, policymakers, competent authorities
and procurement organisations are key influencers in determin-
ing the environment to facilitate LOD and UKD, overcome barriers
to acceptance and support increases in organ donation activity.
Prompted by a change in the UK law in 2006 [41, 42], the wider
transplant community worked together to mirror the success of
the programme in the Netherlands [17, 18]. More than 500 people
have since donated as an unspecified donor and an increasing
number donate into an altruistic donor chain in the UKLKSS [1].
A key driver in the development of the UK programme was
the formation of the ‘Give a Kidney’ charity (www.giveakidney.
org), founded in 2011 by unspecified donors and transplant pro-
fessionals with advisory support from NHSBT, the organisation
with responsibility for organ procurement. The charity was
unique in Europe, but a similar group has since established in
the Netherlands. ‘YouGov’ polls performed in 2011 and repeated
in 2014 demonstrated that the public’s willingness to consider
UD increased by 3% (from 8% to 11%) and awareness about UKD
increased from 67% to 79% in the lifetime of the charity, while
donations from UKDs increased exponentially (from 34 to 118
donors per year) [1].
The activities of the charity and the collaborations with
NHSBT, transplant professionals and the wider NHS helped to
maximise UKD activity across the UK. The willingness of
Trustees to work alongside healthcare professionals dispelled
initial scepticism and achieved credibility and support for the
contribution that the charity makes to the UKD programme—
their ability to generate media and publicity opportunities
through case-based stories has proved invaluable to public
awareness campaigns alone. Such collaborations create mo-
mentum for change, modify behaviours and inspire the whole
organ donation and transplantation community.
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Media interest wains once the novelty of UKD diminishes,
which must be balanced against the greater good that is derived
from UKD becoming ‘the norm’. For an emerging programme,
national news stories—television, radio, Internet and press—
create immediate impact and encourage potential volunteers to
‘consider’ donation [12]. Thereafter, frequent local or regional
stories remind people to put their thoughts into action and initi-
ate the process. Donors of any age are inspired by publicity, re-
gardless of whether it is specifically targeted to their own age
group or not. Young people and UKD are controversial and al-
though people of 18–29 years often express interest in donation,
fewer in this age range proceed. This may reflect general con-
cerns about lifelong risk following kidney donation, influencing
both the approach of transplant professionals and a higher rate
of donor withdrawal from this age group after counselling.
CONCLUSION
This article has explored the approach to UKD across Europe
and identified the primary limitations to increasing donation
from volunteer donors to create more LDKT opportunities for
patients as a treatment of choice for ESRD. In particular, the
potential for unspecified donors to initiate a chain of trans-
plants in the kidney exchange programme significantly benefits
long-waiting patients with immunological complexity, from
BAME communities and those who do not have a suitable living
donor of their own.
Raising awareness to improve knowledge and understand-
ing across all sectors of society, which encourages the public to
volunteer to donate, is appropriate and desirable to increase
UKD. The following recommendations provide a framework
that individual countries can adapt to overcome the primary
limitations to UKD and secure commitment from all the key
players to create an environment for change.
RECOMMENDATIONS
(i) Countries wishing to undertake UKD must have a legal
framework to support LOD and be committed to LDKT and
UKD. Appropriate infrastructure, organisational frame-
works and clinical pathways must be in place to facilitate
donation whilst safeguarding the interests of people who
volunteer to donate.
(ii) UKD offers the best opportunity to maximise transplant
opportunities for patients with ESRD through kidney ex-
change programmes (donor chains).
(iii) Raising awareness by providing stratified information that
is country-specific, culturally sensitive and relevant across
all sectors of society offers a sustainable option for in-
creasing UKD activity.
(iv) The content and context of raising awareness initiatives
must be appropriate for both mature and emerging pro-
grammes and relevant to all target audiences.
(v) Collaboration between dedicated groups—previous unspe-
cified kidney donors, healthcare professionals and pro-
curement organisations—is the most effective model for
engaging with target audiences.
(vi) Competent authorities with support of dedicated groups
are best placed to achieve legislative change in individual
countries.
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